Received Jan 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5J959 | — |
Partial vaccination may have been administered. Potential error where patient did not receive adjuvant along with antigen. Risk management analysis conducted. Per recommendations of MD with Infectious Disease, patient offered repeat dose.